[HTML][HTML] Identification of plasma complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach
PY Kim, O Tan, SM Diakiw, D Carter, EO Sekerye… - Journal of …, 2014 - Elsevier
The majority of patients diagnosed with neuroblastoma present with aggressive disease.
Improved detection of neuroblastoma cancer cells following initial therapy may help in …
Improved detection of neuroblastoma cancer cells following initial therapy may help in …
[PDF][PDF] Identification of plasma Complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach☆
PY Kim, O Tan, SM Diakiw, D Carter, EO Sekerye… - 2013 - researchgate.net
Neuroblastoma is an embryonal tumour of the sympathoadrenal tissues, and is one of the
most common tumours in early childhood [1]. More than half of children with neuroblastoma …
most common tumours in early childhood [1]. More than half of children with neuroblastoma …
[PDF][PDF] Identification of plasma Complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach
PY Kim, O Tan, SM Diakiw, D Carter, EO Sekerye… - 2013 - core.ac.uk
Neuroblastoma is an embryonal tumour of the sympathoadrenal tissues, and is one of the
most common tumours in early childhood [1]. More than half of children with neuroblastoma …
most common tumours in early childhood [1]. More than half of children with neuroblastoma …
[PDF][PDF] Identification of plasma Complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach
PY Kim, O Tan, SM Diakiw, D Carter, EO Sekerye… - 2013 - researchers.mq.edu.au
Neuroblastoma is an embryonal tumour of the sympathoadrenal tissues, and is one of the
most common tumours in early childhood [1]. More than half of children with neuroblastoma …
most common tumours in early childhood [1]. More than half of children with neuroblastoma …
[PDF][PDF] Identification of plasma Complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach
PY Kim, O Tan, SM Diakiw, D Carter, EO Sekerye… - 2013 - research-management.mq.edu.au
Neuroblastoma is an embryonal tumour of the sympathoadrenal tissues, and is one of the
most common tumours in early childhood [1]. More than half of children with neuroblastoma …
most common tumours in early childhood [1]. More than half of children with neuroblastoma …
Identification of plasma complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach.
PY Kim, O Tan, SM Diakiw, D Carter… - Journal of …, 2013 - europepmc.org
The majority of patients diagnosed with neuroblastoma present with aggressive disease.
Improved detection of neuroblastoma cancer cells following initial therapy may help in …
Improved detection of neuroblastoma cancer cells following initial therapy may help in …
[引用][C] Identification of plasma Complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach
PY Kim, O Tan, SM Diakiw, D Carter, EO Sekerye… - Journal of …, 2014 - cir.nii.ac.jp
Identification of plasma Complement C3 as a potential biomarker for neuroblastoma using a
quantitative proteomic approach | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
quantitative proteomic approach | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
[PDF][PDF] Identification of plasma Complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach☆
PY Kim, O Tan, SM Diakiw, D Carter, EO Sekerye… - 2013 - cyberleninka.org
Neuroblastoma is an embryonal tumour of the sympathoadrenal tissues, and is one of the
most common tumours in early childhood [1]. More than half of children with neuroblastoma …
most common tumours in early childhood [1]. More than half of children with neuroblastoma …
[PDF][PDF] Identification of plasma Complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach
PY Kima, O Tana, SM Diakiwa, D Cartera… - 2013 - academia.edu
Neuroblastoma is an embryonal tumour of the sympathoadrenal tissues, and is one of the
most common tumours in early childhood [1]. More than half of children with neuroblastoma …
most common tumours in early childhood [1]. More than half of children with neuroblastoma …
Identification of plasma Complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach
PY Kim, O Tan, SM Diakiw, D Carter, EO Sekerye… - Journal of …, 2014 - infona.pl
The majority of patients diagnosed with neuroblastoma present with aggressive disease.
Improved detection of neuroblastoma cancer cells following initial therapy may help in …
Improved detection of neuroblastoma cancer cells following initial therapy may help in …